Human tauopathies including Alzheimer’s disease, progressive supranuclear palsy and related disorders, are characterized by deposition of pathological forms of tau, synaptic dysfunction and neuronal loss. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.